Skip to main content
CivicGate

SB 262 IN
Became Law

INSPECT program.

IN · session 2026 · Senate · bill

A state bill is a proposed law in a state legislature — separate from the U.S. Congress. Learn more →

Introduced Jan 8, 2026

Latest action (Mar 5, 2026) Signed by the Speaker

Summary

Sets forth the circumstances in which a dispenser is not required to transmit certain information to the INSPECT program (program). Requires an opioid treatment program to, before reporting patient information to the program, comply with federal regulations in obtaining patient consent. Allows the board of pharmacy to disclose prescription drug monitoring program data to a representative of the Indiana department of health and the office of the secretary of family and social services for specified purposes.

Sponsors (3)

2 coauthors / cosponsors

Action history (22)

  1. Jan 8, 2026 First reading: referred to Committee on Health and Provider Services · upper
  2. Jan 8, 2026 Authored by Senator Crider · upper
  3. Jan 15, 2026 Committee report: amend do pass, adopted · upper
  4. Jan 22, 2026 Senator Charbonneau added as second author · upper
  5. Jan 26, 2026 Amendment #2 (Crider) prevailed; voice vote · upper
  6. Jan 26, 2026 Second reading: amended, ordered engrossed · upper
  7. Jan 28, 2026 Cosponsors: Representatives Barrett, Ledbetter · upper
  8. Jan 28, 2026 Third reading: passed; Roll Call 127: yeas 48, nays 0 · upper
  9. Jan 28, 2026 House sponsor: Representative Goss-Reaves · upper
  10. Jan 29, 2026 Referred to the House · upper
  11. Feb 2, 2026 First reading: referred to Committee on Public Health · lower
  12. Feb 17, 2026 Committee report: amend do pass, adopted · lower
  13. Feb 19, 2026 Second reading: ordered engrossed · lower
  14. Feb 23, 2026 Third reading: passed; Roll Call 312: yeas 94, nays 0 · lower
  15. Feb 24, 2026 Motion to concur filed · upper
  16. Feb 24, 2026 Returned to the Senate with amendments · lower
  17. Feb 25, 2026 Senate concurred with House amendments; Roll Call 287: yeas 47, nays 0 · upper
  18. Feb 27, 2026 Signed by the President of the Senate · upper
  19. Mar 5, 2026 Signed by the Governor · executive
  20. Feb 27, 2026 Signed by the President Pro Tempore · upper
  21. Mar 5, 2026 Public Law 133 · upper
  22. Feb 27, 2026 Signed by the Speaker · lower
Subjects
AGENCIES; Department of Health (IDOH)AGENCIES; Family and Social Services Administration (FSSA)AGENCIES; Professional Licensing Agency (PLA)HEALTH CARE FACILITIES; PharmaciesHEALTH CARE PROFESSIONALS; PharmacistsHEALTH; Prescription Drugs and Medications

Full text

The full text hasn’t been imported yet. CivicGate fetches it from the state legislature’s published version documents — check now.

Comments

Comments

Loading comments…

Data from OpenStates. View on OpenStates →